William Mietlowski - Concepedia

Author

William Mietlowski

Also Known As

W L Mietlowski, W Mietlowski, W. Mietlowski, William L Mietlowski, William L. Mietlowski, William Leonard Mietlowski, William Mietlowski

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Dana-Farber Cancer Institute The University of Texas MD Anderson Cancer Center Frontier Science & Technology Research Foundation United States Department of Veterans Affairs

About

William Mietlowski is an author at Novartis (United States) specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	298
2	Engineering	1	1	20
3	Health Sciences	1	1	17
4	Biostatistics	1	1	22
5	Emergency Medicine	1	1	54

William Mietlowski

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle, New England Journal of Medicine	2006	1.3K
Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer Catherine Lhommé, Florence Joly, Joan L. Walker, Journal of Clinical Oncology	2008	154
Cyclosporine as maintenance therapy in patients with severe psoriasis Jerome L. Shupack, Elizabeth Abel, Eugene A. Bauer, Journal of the American Academy of Dermatology	1997	102
A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis Stanley H. Appel, Scott Stewart, Vicki Appel, Archives of Neurology	1988	96
Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung James D. Cox, Raymond Yesner, William Mietlowski, Cancer	1979	94
Levamisole as an adjuvant to chemotherapy in extensive bronchogenic carcinoma. A veterans administration lung cancer group study Stephen Davis, William Mietlowski, Jay J. Rohwedder, Cancer	1982	71
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients David A. Reardon, Charles A. Conrad, Timothy F. Cloughesy, Cancer Chemotherapy and Pharmacology Neuro-oncologyRecurrent Glioblastoma PatientsMedicineReceptor Tyrosine KinasePharmacology	2012	60
Clinical report on the treatment of locally advanced lung cancer Zbigniew Petrovich, William Mietlowski, Maimu Ohanian, Cancer	1977	56
Prognostic grading and significance of ventricular premature beats after recovery from myocardial infarction. Alastair J. Moss, John DeCamilla, William Mietlowski, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) Heart FailureMultivariate CombinationsCardiovascular DiseaseVpb CharacteristicsCoronary Unit	1975	54
Clinical and Magnetic Resonance Imaging Changes Correlate in a Clinical Trial Monitoring Cyclosporine Therapy for Multiple Sclerosis Guo Jun Zhao, David K.B. Li, Jerry S. Wolinsky, Journal of Neuroimaging	1997	37

Page 1